US 10815295
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 10815295 (Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K39/42, A61K45/06, A61P